Friday, July 1, 2022
wellness India Expo
Home Tags Drugs

Tag: drugs

Plastic vials market to surpass US$ 1.9 billion, applications on rise...

Based on end-use, pharmaceuticals & healthcare industry is anticipated to hold around 81% of the market share by the end of 2032

HempStreet partners Israel’s Gynica to develop phytopharma products

The partnership is aimed to bolster the combined R&D efforts to improve women’s health with cannabinoid-based phytomedicine

Deep learning model to predict adverse drug to drug interactions

Using gene expression data, the new model can predict how some drug-drug interactions can lead to adverse effects in the human body

GIST researchers identify new medicines using interpretable deep learning predictions

New drugs are predicted for target proteins using a new, interpretable deep learning-based model with improved prediction and transparency

Lupin signs licensing deal with Alvion to market Cardiometabolic drugs in...

By commercializing cardiometabolic drugs in the Southeast Asian region, Lupin will play a significant role in improving the quality of healthcare

International workshop on taking novel drugs from lab to clinic

The workshop by Drugs for Neglected Diseases Initiative (DNDi), the Indian Society for Clinical Research (ISCR), and Venture Center’s BIRAC Regional Bio-Innovation Center (BRBC) will be held on March 07-11, 2022

Biological E’s COVID-19 vaccine gets EUA nod for 12-18 years age...

The Drugs Controller General of India (DCGI) has already approved CORBEVAX for restricted use in emergency situation among adults on December 28, 2021

Researchers devise new strategy for developing drug molecules

Utilizing the tools of Organic Chemistry and Biophysics to design molecules that target protein interface, researchers developed a universal privileged scaffold approach designing a variety of inhibitors

Global medicine spending to reach $1.8 trillion in 2026: IQVIA study

A total of 300 new drugs are expected to be launched over the next five years to 2026, significantly higher than levels seen on average during the past decade, and are expected to skew toward specialty, niche and orphan drugs

PLI scheme for pharma: Govt approves 42 applications, commits investment of...

In total, 215 applications were received for the domestic manufacturing of 36 products spread across the 4 target segments including critical KSMs, Drug Intermediates and APIs